Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROPHETIC - Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

NCT04056247 is registered in ClinicalTrials.gov with OncoHost Ltd. as lead sponsor.

NCT NCT04056247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04056247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROPHETIC - Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
Lead sponsor
OncoHost Ltd.
Phase
Observational
Overall status
Active, not recruiting
Start date
October 1, 2019
Completion date
October 1, 2029
Enrollment
10,000 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii unresectable non-small cell lung cancer, stage iiib-d malignant melanoma, stage iv malignant melanoma, stage iv non-small cell lung cancer, stage iv small cell lung cancer